-
3 weeks ago | 
healio.com | Heather Biele |Edward Kim
City of Hope has named Hope S. Rugo, MD, as its new director of the Women’s Cancers Program and chief of the breast medical oncology division, according to a press release. Rugo, also professor in the department of medical oncology and therapeutics research at City of Hope, most recently served in various clinical and academic leadership roles during a 35-year career at the University of California San Francisco.
-
3 weeks ago | 
healio.com | Matthew Shinkle |Heather Biele
Key takeaways: Chronic cutaneous immune-related adverse events often persist more than a year after discontinuation of immune checkpoint inhibitor therapy. The findings highlight the importance of dermatology referral. Cutaneous immune-related adverse events that develop after immune checkpoint inhibitor therapy become chronic in nearly one-quarter of cases, according to a research letter published in JAMA Dermatology.
-
3 weeks ago | 
healio.com | Sara Kellner |Heather Biele
Key takeaways: A patient navigation program addressed barriers to getting a colonoscopy, including insurance and transportation. Patients were 69% more likely to get a colonoscopy with patient navigation vs. usual care. A patient navigation program significantly improved the odds that people would get a colonoscopy after receiving an abnormal fecal immunochemical test result, according to a study published in Annals of Internal Medicine.
-
4 weeks ago | 
healio.com | Jennifer Southall |Heather Biele
Key takeaways: Researchers envision training the algorithm to help cardiologists identify liver disease from subcostal views. A few next steps are needed before researchers can test the algorithm out in the clinic. An AI-based algorithm may help detect chronic liver disease using images from standard echocardiography, according to study results published in NEJM AI.
-
4 weeks ago | 
healio.com | Josh Friedman |Heather Biele
Read more Key takeaways: Pyronaridine, a common malaria drug, has been used for more than 50 years. The agent could be repurposed to treat various cancer types, including leukemia, lymphoma and breast cancer. A common malaria drug could be repurposed to treat a variety of hematologic cancers and solid tumors, according to early study results. Researchers found pyronaridine disrupts an enzyme critical to cellular division and can cause cancer cell death.
-
4 weeks ago | 
healio.com | Matthew Shinkle |Heather Biele
Key takeaways: Exercise 3 days per week improved sexual function for men with prostate cancer vs. usual care. Exercise also improved fat mass and muscle strength. Exercise improved erectile dysfunction compared with standard care among men with prostate cancer, according to study results published in JAMA Network Open. Men who are concerned about sexual dysfunction should be offered exercise as a potential rehabilitation strategy after treatment, researchers concluded.
-
4 weeks ago | 
healio.com | Heather Biele |Margaret Foti
Crystal L. Mackall, MD, renowned for her “pioneering work in CAR T-cell therapy,” will receive this year’s American Association for Cancer Research-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology. The award, which will be presented April 29 at AACR Annual Meeting in Chicago, recognizes and celebrates active researchers whose investigations have made a significant impact in oncology.
-
4 weeks ago | 
healio.com | Josh Friedman |Heather Biele
Key takeaways: One in six participants in phase 2 cancer trials received a therapy that gained FDA approval. The results demonstrate phase 1 trials help filter out unsafe or ineffective drugs, investigators concluded. Jonathan Kimmelman, PhD, has published multiple research papers and gotten into an inordinate number of debates about the clinical value of phase 1 trials.
-
4 weeks ago | 
healio.com | Mark Leiser |Heather Biele |Gabrielle B. Rocque
Gabrielle B. Rocque, MD, MSPH, FASCO These investigators aimed to determine if a remote symptom monitoring program using electronic patient-reported outcomes improves fatigue among patients with metastatic breast cancer. This is an incredibly patient-centric question. Seventy percent of people in the study population had visceral disease and approximately half were on chemotherapy.
-
1 month ago | 
healio.com | Jennifer Southall |Heather Biele
Key takeaways: More than 25% of respondents in academic roles reported that their work was not academically acknowledged. Recommendations to address these concerns include name recognition and financial compensation. Women in science communication roles within scientific societies reported feeling personal responsibility for the work, despite being underpaid and undervalued, according to study results published in Science Communication.
